Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07013981Not ApplicableCompleted

The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO)in Tokyo: Open Trial

Role: collaborator

NCT01817699Phase 4Terminated

Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients

Role: collaborator

NCT00928824Not ApplicableCompleted

Can Japanese Traditional Foods Lower Blood Pressure in Healthy Volunteers

Role: collaborator

All 3 trials loaded